Clinical Trial Update: Effect of Respiratory Exerciser on Pulmonary Functions of COVID-19 Patients

View source ↗

Summary

A completed clinical trial evaluating the effect of a respiratory exerciser on pulmonary function in COVID-19 patients; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection
• Pneumonia Viral
• Respiratory Function Loss

Snippet

Sponsor: Diskapi Yildirim Beyazit Education and Research Hospital | Conditions: Covid19, Respiratory Function Loss | Status: COMPLETED | Results posted: 2022-01-31